Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,948
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Location: Dallas TX, Kansas City MO, St Louis MO, Birmingham AL,
Sponsor: Milton S. Hershey Medical Center
Sex: All
Age: 0 - 30
Code: NCT06541262
Phase 1, Phase 2, Recruiting
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
for
Hemophilia B
Location: Dallas TX, Houston TX, New Orleans LA, Nashville TN,
Sponsor: Regeneron Pharmaceuticals
Sex: Male
Age: 2+
Code: NCT06379789
Phase 1, Phase 2, Recruiting
Catheter-Related Early Thromboprophylaxis With Enoxaparin Studies
for
Deep Venous Thrombosis
Location: Dallas TX, Oklahoma City OK, Austin TX, Little Rock AR,
Sponsor: Yale University
Sex: All
Age: 0 - 17
Code: NCT04924322
Phase 2, Phase 3, Recruiting
MASA Valve Early Feasibility Study
for
Tetrology of Fallot, Pulmonary Stenosis, Truncus Arteriosus,
Location: Dallas TX, Peoria IL, Cincinnati OH, Philadelphia PA,
Sponsor: PECA Labs
Sex: All
Age: 0 - 22
Code: NCT05452720
Recruiting
Study to Evaluate the Efficacy and Safety of BMN 333 Versus Vosoritide in Children With Achondroplasia
for
Achondroplasia
Location: Dallas TX, Houston TX, San Antonio TX, Chicago IL,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 2 - 17
Code: NCT07441876
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Location: Dallas TX, Durham NC, New York NY, Palo Alto CA,
Sponsor: Stanford University
Sex: All
Age: 0 - 16
Code: NCT06080074
Phase 2, Recruiting
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
for
Type 1 Diabetes
Location: Dallas TX, Fort Worth TX, Houston TX, San Antonio TX,
Sponsor: SAb Biotherapeutics, Inc.
Sex: All
Age: 5 - 40
Code: NCT07187531
Phase 2, Recruiting
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
for
Niemann-Pick Type C Disease, GM1 Gangliosidosis,
Location: Dallas TX, Rochester MN, Minneapolis MN, Fairfax VA,
Sponsor: Azafaros B.V.
Sex: All
Age: 4+
Code: NCT07054515
Phase 3, Recruiting
Augmented Reality-Cardiopulmonary Resuscitation Support for Pediatric Resuscitation
Location: Dallas TX, Houston TX, St. Petersburg FL, Toronto,
Sponsor: Johns Hopkins University
Sex: All
Age: 18+
Code: NCT07778823
Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
for
Atypical Teratoid/Rhabdoid Tumor,
Location: Dallas TX, Little Rock AR, Kansas City KS, St Louis MO,
Sponsor: Milton S. Hershey Medical Center
Sex: All
Age: 0 - 26
Code: NCT06465199
Phase 1, Phase 2, Recruiting
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
for
Acute Myeloid Leukemia
Location: Dallas TX, Nashville TN, Atlanta GA, Valhalla NY,
Sponsor: AbbVie
Sex: All
Age: 0 - 17
Code: NCT07306832
Phase 1, Recruiting
Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
for
Von Willebrand Disease (VWD)
Location: Dallas TX, Little Rock AR, Atlanta GA, Minneapolis MN,
Sponsor: Vega Therapeutics, Inc
Sex: All
Age: 12 - 70+
Code: NCT07115004
Phase 3, Recruiting
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Dallas TX, Fort Worth TX, Oklahoma City OK, Houston TX,
Sponsor: Center for International Blood and Marrow Transplant Research
Sex: All
Age: 0+
Code: NCT01351545
Recruiting
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies